This roadmap aims to nurture, promote and facilitate Home Languages across education systems in Europe. It provides resources at a transnational, national, regional and local school-policy level. It ...

NKT-3447 is under clinical development by NiKang Therapeutics and currently in Phase I for Endometrial Cancer. According to GlobalData, Phase I drugs for Endometrial Cancer have an 81% phase ...

NKT-3447 is under clinical development by NiKang Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 70% phase transition success rate ...

Our german-language newsletter will keep you up to date with our programme.

Please register yourself for unlimited free access. Redirecting to register page ...

YourLifeChoices is Australia’s most established and trusted digital publication for the 50+ audience, with a core focus on helping Australians navigate midlife and the retirement landscape. Since 2000 ...